JPS5827246B2 - Method for producing electrolyte compound mixed powder for bicarbonate dialysis - Google Patents

Method for producing electrolyte compound mixed powder for bicarbonate dialysis

Info

Publication number
JPS5827246B2
JPS5827246B2 JP55165121A JP16512180A JPS5827246B2 JP S5827246 B2 JPS5827246 B2 JP S5827246B2 JP 55165121 A JP55165121 A JP 55165121A JP 16512180 A JP16512180 A JP 16512180A JP S5827246 B2 JPS5827246 B2 JP S5827246B2
Authority
JP
Japan
Prior art keywords
powder
electrolyte compound
acetic acid
weight
sodium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55165121A
Other languages
Japanese (ja)
Other versions
JPS5788116A (en
Inventor
武 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tomita Pharmaceutical Co Ltd
Original Assignee
Tomita Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomita Pharmaceutical Co Ltd filed Critical Tomita Pharmaceutical Co Ltd
Priority to JP55165121A priority Critical patent/JPS5827246B2/en
Publication of JPS5788116A publication Critical patent/JPS5788116A/en
Publication of JPS5827246B2 publication Critical patent/JPS5827246B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は重炭酸透析用電解質化合物混合粉末の製造方法
、更に詳しくは単に水に溶解させるのみで、特定の電解
質イオンと適当なpHとを有し、重炭酸透析用人工潅流
液調整時に急激なpHの変動やカルシウム塩、マグネシ
ウム塩の析出が起らず、また上記潅流液中での化学反応
が緩やかに進行して、重炭酸透析用人工潅流液本来の優
れた効果を常に安定して奏し得る新して粉末状の電解質
化合物混合物の製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for producing an electrolyte compound mixed powder for bicarbonate dialysis, and more specifically, by simply dissolving it in water, it has specific electrolyte ions and an appropriate pH, During the preparation of the artificial perfusate, rapid pH fluctuations and precipitation of calcium and magnesium salts do not occur, and the chemical reactions in the perfusate proceed slowly, resulting in the original excellent artificial perfusate for bicarbonate dialysis. The present invention relates to a method for producing a new powdered electrolyte compound mixture that can always exhibit stable effects.

重炭酸透析用人工潅流液とは、パイカーボネート透析液
とも呼ばれ、血液透析に用いられる人工腎臓用潅流剤の
ひとつである。
The artificial perfusion solution for bicarbonate dialysis, also called picarbonate dialysate, is one of the perfusion agents for artificial kidneys used in hemodialysis.

これは通常血液透析に必要な各種電解質化合物を溶かし
た液(A液又は主原料)とアルカリ剤としての重炭酸す
) 17ウム(NaHCo 3 )水溶液(B液又は副
原料)との組み合せ用剤として、透析時に両者を混合し
て人工腎臓装置に潅流して用いられている。
This is usually a combination of a solution containing various electrolyte compounds necessary for hemodialysis (Liquid A or main raw material) and an aqueous solution of bicarbonate (NaHCo3) as an alkaline agent (Liquid B or auxiliary raw material). During dialysis, the two are mixed and perfused into an artificial kidney device.

上記透析液は、アルカリ剤として用いられる重炭酸ナト
リウムが本来体液pHの直接の調整因子として知られる
通り生理的に適切なもので、代謝性アシド−シスや呼吸
性アルカローシス等の酸塩基平衡の改善を効率良くしか
も速やかになし得る速効性を示し、また透析中低血圧や
悪心等の不定愁訴が少なく、急速除水が可能で、高カリ
ウム血症、低カルシウム血症、高リン血症、高アセテー
ト血症等の是正に、特に大面積・短時間透析にその有効
性・安全性が大いに期待されるものである。
The above dialysate is physiologically appropriate, as sodium bicarbonate used as an alkaline agent is known to be a direct regulator of body fluid pH, and improves acid-base balance in metabolic acidosis, respiratory alkalosis, etc. It exhibits fast-acting properties that can efficiently and quickly perform dialysis, and there are fewer indeterminate complaints such as hypotension and nausea during dialysis, and rapid water removal is possible. It is highly expected to be effective and safe for correcting acetateemia, especially for large-area, short-time dialysis.

しかしながら上記アルカリ剤(B液)として利用される
重炭酸ナトリウムは、溶解度が低く、pHや熱などに不
安定で、これをA液と混合して透析液を調製する際及び
その後経時的に炭酸ガスを発生し、pHの上昇及び炭酸
ガス圧の低下を惹起し、これによってA液中のカルシウ
ム、マグネシウムを炭酸塩として沈殿析出させるという
致命的欠点がある。
However, the sodium bicarbonate used as the alkaline agent (solution B) has low solubility and is unstable to pH and heat. This has the fatal disadvantage of generating gas, causing an increase in pH and a decrease in carbon dioxide pressure, which causes calcium and magnesium in Solution A to precipitate out as carbonates.

従って従来上記パイカーボネート透析液の調製に当って
は、透析液のpHを中性に保持するために混合タンク(
反応槽)内に炭酸ガスを導入して脱気される炭酸ガスを
補う方法や、上記反応槽中もしくはA液中に適当量の塩
酸や酢酸を添加してpH調節を行なうと共にA液及びB
液をできるだけ希薄な溶液として均一に混合する方法等
の煩雑な操作や高精度の濃度、pH管理等を要している
Therefore, conventionally, when preparing the above-mentioned picarbonate dialysate, in order to keep the pH of the dialysate neutral, a mixing tank (
A method of introducing carbon dioxide into the reaction tank to supplement the degassed carbon dioxide, or adding an appropriate amount of hydrochloric acid or acetic acid into the reaction tank or into the A liquid to adjust the pH and
This requires complicated operations such as a method of uniformly mixing the liquid as dilute a solution as possible, as well as highly accurate concentration and pH control.

殊にA液に適当な酸を添加して予めpH調節を行なう方
法は、装置及び操作的には可能であるが、A液自体液剤
である所から放置安定性に問題があり、予め所定量の酸
を均一に添加混合しても、貯蔵等による経時的液性の変
動は避は難く、実用上品質変化による不測の危険を招く
おそれがある。
In particular, the method of adjusting the pH in advance by adding an appropriate acid to Solution A is possible in terms of equipment and operation, but since Solution A itself is a liquid agent, there is a problem with storage stability. Even if the acid is uniformly added and mixed, it is difficult to avoid fluctuations in liquid properties over time due to storage, etc., and there is a risk that unforeseen dangers due to changes in quality may occur in practice.

しかも上記A液は運搬等の取扱いの面でも容積及び重量
が大きく極めて不便である以上のようにパイカーボネー
ト透析液は、その透析効果における有効性が非常に高く
注目されているにかかわらず、その調製上の煩雑さ、濃
度、温度、pH等の液性の制限及び管理の複雑さ、並び
に貯蔵、運搬等における不便さの面で、実用上向解消さ
れるべき各種の問題点を有している。
Moreover, the above-mentioned solution A has a large volume and weight, making it extremely inconvenient to transport and handle.As mentioned above, picarbonate dialysate is highly effective in its dialysis effects, and is attracting attention. There are various problems that need to be resolved in practical terms, such as complexity in preparation, limitations on liquid properties such as concentration, temperature, and pH, and complexity in management, as well as inconvenience in storage, transportation, etc. There is.

本発明者は上記パイカーボネート透析液に見られる各種
の利点、即ち代謝性アジド−シス改善効果が迅速且つ効
率よく行なわれ、頭痛、嘔吐、嘔気、胸痛、動悸、血圧
下降、痙れん等の不定愁訴の非常に少ない点を重視し、
該透析液の調製、管理等を容易ならしめる技術を開発す
ることを目的として種々研究を重ねてきた。
The present inventor has discovered various advantages found in the above-mentioned picarbonate dialysate, namely, that the effect of improving metabolic azidosis occurs quickly and efficiently, and that it improves the effects of headache, vomiting, nausea, chest pain, palpitations, decreased blood pressure, convulsions, etc. Focusing on the fact that there are very few complaints,
Various studies have been conducted with the aim of developing techniques that will facilitate the preparation and management of the dialysate.

その過程において上記酸によるpH調節後のA液を粉末
化するという新しい着想から実際にこれを噴霧乾燥した
が、酸成分のほとんどすべては乾燥時に飛散し、得られ
る粉末は、これを再度水に溶解する際所望の酸性pHを
保持し得す、実用に際してはやはり従来通りB液との混
合時にpH調節のための酸の添加が必要となることを認
めた。
In the process, I came up with a new idea of powdering Solution A after adjusting the pH with the acid mentioned above, and actually spray-dried it. However, almost all of the acid components were scattered during drying, and the resulting powder was mixed with water again. Although the desired acidic pH can be maintained during dissolution, it has been recognized that in practical use, it is still necessary to add an acid to adjust the pH when mixing with liquid B as in the past.

また電解質化合物等の粉末を意図的に酸性とする場合、
一般的には酸洗い等の方法に従い、上記粉末表面に直接
酸を付着させる方法が考えられるが、通常入手される電
解質化合物結晶や粉末に上記方法を適用して所望の酸を
付着させれば粉末は湿潤状態となり所期の粉末状態を保
持し得す、之を乾燥する時にはやはり酸の飛散が起り目
的を達成し得ないことを認めた。
In addition, when powders such as electrolyte compounds are intentionally made acidic,
Generally speaking, it is possible to attach acid directly to the surface of the above powder by following a method such as pickling, but if the above method is applied to commonly available electrolyte compound crystals or powder to attach the desired acid. It was recognized that the powder became wet and could maintain the desired powder state, but when it was dried, acid scattering still occurred and the purpose could not be achieved.

しかるに引き続く研究において、本発明者は上記電解質
化合物中主要成分である塩化ナトリウムにつき、これを
マイクロナイザーで約20〜30μ流の超微粉とし、こ
れに氷酢酸を噴霧する時には、所望のpH調節を行ない
得る量の酢酸の添加によっても何ら乾燥を要することな
く粉体流動性に富む酢酸性化された塩化ナトリウム粉末
が製造され、従ってこれを血液透析に必要な他の電解質
化合物と粉体混合することによって、目的とするpH調
節されたA液の粉末化が行ない得、しかもこの粉剤は容
易に密封包装でき、取り扱いが簡便でまた経時的にも極
めて安定であることを見い出した。
However, in subsequent research, the present inventor found that sodium chloride, which is the main component in the electrolyte compound, was made into an ultrafine powder of about 20 to 30 microns using a micronizer, and when glacial acetic acid was sprayed onto it, the desired pH could be adjusted. Addition of as much acetic acid as possible produces an aceticated sodium chloride powder with excellent powder flowability without the need for any drying, which can then be powder mixed with other electrolyte compounds required for hemodialysis. It has been found that the desired pH-adjusted solution A can be powdered by this method, and that this powder can be easily sealed and packaged, is easy to handle, and is extremely stable over time.

本発明はこの新しい知見に基づいて完成されたものであ
る。
The present invention was completed based on this new knowledge.

即ち本発明は、重炭酸透析用人工潅流液を調製するため
の電解質化合物を粉体混合して、NaC1、KCl、C
aCl2・2H20,MgCl2・6H20及びCH3
COONaもしくはCH3COONa −3H20から
成る電解質化合物混合粉末を得る方法であって上記電解
質化合物の主要成分である塩化す) IJウム粉末とし
て、予めマイクロナイザーで約20〜30μ扉の超微粉
とし、次いでこれに氷酢酸の2〜4重量%を噴霧添加し
て酢酸酸性とした塩化ナトリウム粉末を用いることを特
徴とする重炭酸透析用電解質化合物混合粉末の製造方法
に係る。
That is, in the present invention, electrolyte compounds for preparing an artificial perfusion solution for bicarbonate dialysis are mixed in powder form, and NaCl, KCl, C
aCl2・2H20, MgCl2・6H20 and CH3
This is a method for obtaining an electrolyte compound mixed powder consisting of COONa or CH3COONa-3H20, in which chloride, which is the main component of the electrolyte compound, is used. The present invention relates to a method for producing an electrolyte compound mixed powder for bicarbonate dialysis, characterized by using sodium chloride powder made acidic by acetic acid by spraying 2 to 4% by weight of glacial acetic acid.

本発明方法によれば、単に水に溶解させるのみで、所望
のpH値に調節され、バイカーボネート透析液用A液と
して極めて有用な電解質化合物混合粉末を製造できる。
According to the method of the present invention, it is possible to produce an electrolyte compound mixed powder that is adjusted to a desired pH value and is extremely useful as solution A for bicarbonate dialysate by simply dissolving it in water.

該粉末製品は、粉剤であることに基づいて密封包装によ
り貯蔵、運搬等の簡便な製品とすることができ、しかも
該製品は長期保存によってもpHの変動をはじめとする
何らの品質の変動も実質的に起らず、常に安定して一定
の品質を具備する。
Since the powder product is a powder, it can be easily stored and transported in sealed packaging, and the product does not suffer from any changes in quality, including pH changes, even during long-term storage. It does not substantially occur and always has a stable and constant quality.

更に最も重要なことに本発明方法により得られる粉剤製
品は、これを水に溶解してA液として利用する際、B液
との混合によっても異常な炭酸ガスの発生、炭酸ガス圧
の低下、局所的pHの上昇が起らず、カルシウムやマグ
ネシウムが炭酸塩として沈殿析出するおそれも実質的に
ない。
Furthermore, most importantly, when the powder product obtained by the method of the present invention is dissolved in water and used as liquid A, even when mixed with liquid B, abnormal carbon dioxide generation, decrease in carbon dioxide pressure, No local pH increase occurs, and there is virtually no risk that calcium or magnesium will precipitate as carbonate.

従って極めて容易に常に安定して適性なpH1電解質イ
オン組成、炭酸イオン濃度、炭酸ガス圧等を示すパイカ
ーボネート透析液を調製することが可能である。
Therefore, it is possible to very easily prepare a picarbonate dialysate that is always stable and exhibits appropriate pH1 electrolyte ion composition, carbonate ion concentration, carbon dioxide gas pressure, etc.

勿論本発明方法によって得られる粉剤製品により調製さ
れるパイカーボネート透析液は、それ本来の代謝性アン
ド−シス改善効果や不定愁訴の減少等の各種の優れた血
液透析効果は何ら悪影響を受けることなく、むしろ透析
液の調製が容易で、品質のバラツキがないことに基づい
て一層顕著に発現される。
Of course, the picarbonate dialysate prepared from the powder product obtained by the method of the present invention has various excellent hemodialysis effects such as improvement of metabolic and dialysis and reduction of indefinite complaints without any adverse effects. , rather, it is more pronounced because the dialysate is easy to prepare and there is no variation in quality.

以上のように本発明は、優れた血液透析効果を発揮する
パイカーボネート透析液を容易に調製可能とし、取扱い
が簡単で、しかも常に安定して一定の品質を具備する、
従来例を見ない新しい電解質化合物混合粉末製品を提供
するものであり、その工業的価値は絶大なものである。
As described above, the present invention makes it possible to easily prepare a picarbonate dialysate that exhibits excellent hemodialysis effects, is easy to handle, and always has a stable quality.
The present invention provides a new electrolyte compound mixed powder product that has never been seen before, and its industrial value is enormous.

本発明においては、特殊な方法で処理した酢酸酸性塩化
ナトリウム粉末を用いることを必須とする。
In the present invention, it is essential to use acetic acid acidic sodium chloride powder treated by a special method.

該方法において原料とする塩化ナトリウムとしては、具
体的には日本薬局方に収録されるNaC199,5%以
上を含む結晶もしくは結晶性粉末を用いる。
As the sodium chloride used as a raw material in this method, specifically, crystals or crystalline powder containing 199.5% or more of NaC as recorded in the Japanese Pharmacopoeia are used.

これは通常500〜600μ扉程度の大きさを有してお
り、本発明ではこれをマイクロナイザーを用いて約20
〜30μ扉の粒度の超微粉とする。
This normally has a size of about 500 to 600 μm door, and in the present invention, this size is about 20 μm using a micronizer.
Ultra-fine powder with a particle size of ~30 μm.

用いられるマイクロナイザーとしては特に制限はないが
、粉砕と分級とを同時に行ない得、所望の粒度のものを
取り出し得る型式のものが好ましく、そのローター回転
数は7000〜8000r、pomが、またセパレータ
ー回転数は2000〜3000r、p、mの間とするの
が好適である。
There are no particular restrictions on the micronizer used, but it is preferable to use a micronizer that can perform pulverization and classification at the same time and extract particles of the desired particle size. Preferably, the number is between 2000 and 3000 r, p, m.

上記により調製される塩化ナトリウムの粒度は、引き続
く氷酢酸の噴霧添加の際必要量の氷酢酸を添加しても尚
塩化ナトリウムが乾燥せずども粉末状態を保持するか否
かに重要な影響を与え、上記約20〜30μ扉の範囲に
おいて良好な粉末状態を保持する。
The particle size of the sodium chloride prepared as described above has an important influence on whether the sodium chloride does not dry out and remains in powder form even after adding the required amount of glacial acetic acid during the subsequent spray addition of glacial acetic acid. It maintains a good powder state in the above range of about 20 to 30 μm.

次いで本発明では、上記超微細塩化ナトリウムに氷酢酸
を噴霧添加する。
Next, in the present invention, glacial acetic acid is added to the ultrafine sodium chloride by spraying.

これは具体的には、例えば回転攪拌槽等の適当な容器内
にて行なわれる。
This is specifically carried out in a suitable container, such as a rotating stirring tank.

氷酢酸としては、日本薬局方記載のCH3CO0H(6
0,05)99.0%以上を含むもの又はJIS、試薬
特級を用いる。
As glacial acetic acid, CH3CO0H (6
0.05) Use one containing 99.0% or more or JIS, reagent special grade.

その噴霧添加は具体的には、例えば回転攪拌槽の中央部
にセットした加圧ノズルを利用して行ない得る。
Specifically, the spray addition can be carried out using, for example, a pressure nozzle set in the center of a rotating stirring tank.

氷酢酸の噴霧添加量は、塩化ナトリウム重量の2〜4重
量%の範囲とする。
The amount of glacial acetic acid spray added ranges from 2 to 4% by weight of the weight of sodium chloride.

この範囲内での添加によって得られる酢酸酸性化した塩
化ナトリウムが粉末状態を保持し、しかもこれを利用し
て得られる本発明の電解質化合物混合粉末をバイカーボ
ネート透析液用A液とする際該A液が理想的なpH即ち
約45前後を呈することができる。
The sodium chloride acidified with acetic acid obtained by adding within this range maintains a powder state, and when the electrolyte compound mixed powder of the present invention obtained by using this is used as solution A for bicarbonate dialysate. The liquid can exhibit an ideal pH, ie around 45.

かくして得られる酢酸酸性塩化ナトリウム粉末が優れた
粉体流動性を有するのは、噴霧された霧状の氷酢酸に無
数の超微粉塩化ナトリウム粒子が吸着し、2等超微粉塩
化ナトリウム粒子群が上記酢酸筒を包んだ形態で上記粉
末が構成されるためと考えられる。
The reason why the thus obtained acetic acid-acidic sodium chloride powder has excellent powder fluidity is that countless ultrafine powder sodium chloride particles are adsorbed to the sprayed atomized glacial acetic acid, and the second grade ultrafine powder sodium chloride particle group is This is thought to be because the above powder is configured in the form of a cylinder of acetic acid.

いずれにせよかくして得られる粉末は、長期間安定で粉
体流動性を有しており、何ら乾燥せずども他の電解質化
合物と容易に粉体混合することができる。
In any case, the powder thus obtained is stable for a long period of time, has powder fluidity, and can be easily mixed with other electrolyte compounds without any drying.

本発明方法においては、上記で製造した酢酸酸性化塩化
ナトリウム粉末を他の電解質化合物と粉体混合して所期
の重炭酸透析液用電解質化合物混合粉末を得る。
In the method of the present invention, the acetic acid acidified sodium chloride powder produced above is mixed with other electrolyte compounds to obtain the desired electrolyte compound mixed powder for bicarbonate dialysate.

他の電解質化合物としては、この種透析液用原料として
用いられる通常の化合物具体的には日本薬局方、食品添
加物公定書等に収載され、またJIS規格試薬とされる
塩化カリウム(KCI)、塩化カルシウム(CaC12
・2H20)、塩化マグネシウム(Mg C12・6H
20)、酢酸ナトリウム(CH3COONa又はCH3
COONa−3H20)等を利用できる。
Other electrolyte compounds include common compounds used as raw materials for this type of dialysate, specifically potassium chloride (KCI), which is listed in the Japanese Pharmacopoeia, the Official Food Additives Standard, etc., and is also a JIS standard reagent. Calcium chloride (CaC12
・2H20), magnesium chloride (Mg C12・6H
20), sodium acetate (CH3COONa or CH3
COONa-3H20) etc. can be used.

之等各電解質化合物の混合は、通常の方法により行なわ
れ、またその混合比率は、得られる混合粉末を水に溶解
後B液(NaHCO3液)と混合して調製されるバイカ
ーボネート透析液が次のイオン組成を有するように適宜
に決定される。
The mixing of each of these electrolyte compounds is carried out in a conventional manner, and the mixing ratio is as follows: The ionic composition is determined as appropriate.

C11 H3COO CO3 35〜140mEq/J O〜4.0rrLEq/1 2、5〜3.5 mEq/1 1、 O〜1.5 mEq/1 06〜107.5 mEq/1 4〜9mEq/J 7、5〜35 mEq/J 上記イオン組成を有する透析液は、より好ましくは重量
比で以下の各電解質化合物及び NaHCO3を含む。
C11 H3COO CO3 35-140mEq/J O-4.0rrLEq/1 2, 5-3.5 mEq/1 1, O-1.5 mEq/1 06-107.5 mEq/1 4-9mEq/J 7, 5 to 35 mEq/J The dialysate having the above ionic composition preferably contains the following electrolyte compounds and NaHCO3 in a weight ratio.

aCI KCI CaCClCaCl2 一2H20・6H20 CH3COONa NaHCO3 59,474〜62,6 1.157〜1.99 0.978〜2,73 0.676〜1,63 1.455〜6.59 24.763〜30.5 44重量% 8 〃 8 〃 4 〃 5 〃 62 〃 本発明混合粉末は、これを密封包装することによって長
期に亘って保存性に優れしかも取扱い等の面でも極めて
簡便な製品とすることができる。
aCI KCI CaCClCaCl2 -2H20・6H20 CH3COONa NaHCO3 59,474~62,6 1.157~1.99 0.978~2,73 0.676~1,63 1.455~6.59 24.763~30. 5 44% by weight 8 〃 8 〃 4 〃 5 〃 62 〃 By sealing the mixed powder of the present invention, it can be made into a product that has excellent storage stability over a long period of time and is extremely easy to handle. .

また該製品は、これを適当量の水に溶解するのみで、バ
イカーボネート透析液用A液として用いることができ、
かくして得られるA液は、B液との混合時に新たに酸を
添加したり、混合槽内に炭酸ガスを吹き込んだすせずと
も、充分な効果が期待できる。
In addition, this product can be used as solution A for bicarbonate dialysate simply by dissolving it in an appropriate amount of water.
The thus obtained liquid A can be expected to have sufficient effects even without adding new acid or blowing carbon dioxide gas into the mixing tank when mixing with liquid B.

以下本発明を更に詳しく説明するため実施例及び参考例
を挙げる。
Examples and reference examples are given below to explain the present invention in more detail.

実施例 ■ 日本薬局方記載の塩化ナトリウム100kgをマイクロ
ナイザー(衝撃式粉砕機、8000回転/分)で粉砕し
て約20〜30μ爪の超微粉とする次いで上記超微粉塩
化ナトリウムに氷酢酸(JIS試薬特級、CH3CO0
H99,5%以上)3重量剖を噴霧添加する。
Example ■ 100 kg of sodium chloride as described in the Japanese Pharmacopoeia is crushed using a micronizer (impact type crusher, 8000 rpm) to obtain an ultra-fine powder of about 20 to 30 micron nails. Next, the ultra-fine powder of sodium chloride is mixed with glacial acetic acid (JIS). Special grade reagent, CH3CO0
Add H99, 5% or more) by spraying.

上記により得られる酢酸酸性塩化ナトリウム粉末(CH
3COOH酸性NaC1)に、下記各電解質化合物を粉
体混合する。
Acetic acid sodium chloride powder (CH
The following electrolyte compounds are mixed in powder form into 3COOH acidic NaC1).

CH3CO0H酸性NaCI KCI(日局) CaC12・2H20(日局 MgCl2・6H20(食添 CH3CO0Na(食添) 87.560重量% 2.624 II ) 3.622 // ) 2.146 // 4.048 〃 かくして本発明の重炭酸透析液用電解質化合物混合物粉
末を得る。
CH3CO0H acidic NaCI KCI (Japanese Bureau) CaC12・2H20 (Japanese Bureau MgCl2・6H20 (Food Additive CH3CO0Na (Food Additive) 87.560% by weight 2.624 II ) 3.622 // ) 2.146 // 4.048 〃 Thus, the electrolyte compound mixture powder for bicarbonate dialysate of the present invention is obtained.

参考例 1 実施例1で得た各ロット毎の粉末(A) 2.4861を夫々101の水に溶解して、pH4,5
の重炭酸透析用電解質溶液(A液)試料(ロツ)Al〜
5)を得る。
Reference Example 1 Powder (A) 2.4861 for each lot obtained in Example 1 was dissolved in 101 water and adjusted to pH 4.5.
Electrolyte solution for bicarbonate dialysis (liquid A) sample (lots) Al~
5) is obtained.

また日本薬局方記載の重炭酸ナトリウム粉末(NaHC
O2)882’fl宛を夫夫201!の水に溶かして、
pH8,1の重炭酸ナトリウム水溶液(B液)を得る。
In addition, sodium bicarbonate powder (NaHC) described in the Japanese Pharmacopoeia
O2) Addressed to 882'fl, husband 201! Dissolve in water,
Obtain an aqueous sodium bicarbonate solution (solution B) with a pH of 8.1.

上記A液及びB液を、夫々多人数透析液供給装置(株式
会社ニグロ製 KH−20AB型)の主原液タンク及び
重曹水タンクに夫々仕込み、混合タンク内で全量が35
07となる様温水(35〜40℃)で希釈しながら順次
供給タンク及びコンソールへ送り、重炭酸透析液とした
時の電解質イオン濃度(TrLEq/l)は、末端コン
ソール部で、下記第1表に示す通りであった。
The above A and B solutions were respectively charged into the main stock solution tank and the sodium bicarbonate water tank of a multi-dialysate supply device (KH-20AB type manufactured by Nigro Co., Ltd.), and the total amount in the mixing tank was 35.
The electrolyte ion concentration (TrLEq/l) when the bicarbonate dialysate is diluted with warm water (35 to 40°C) and sent to the supply tank and console in order to obtain 0.07 is as shown in Table 1 below at the end console It was as shown in

尚Na+、K+イオンについては炎光光度計(I、L、
モデル343、米国インストルメンテーション ラボラ
トリ−(1、L)社製)により、HCO3イオンについ
てはガス分析装置(1,L、メーター、マイクロ13、
米国1.L社製)により、またCa2+、Mg2+、C
H3COO及びCI イオンについては、日本薬局方
及び食品添加物公定書記載の定量法により夫々その濃度
を測定した。
For Na+ and K+ ions, use a flame photometer (I, L,
For HCO3 ions, a gas analyzer (1,L, meter, micro 13,
United States 1. (manufactured by Company L), and Ca2+, Mg2+, C
The concentrations of H3COO and CI ions were measured using the quantitative methods described in the Japanese Pharmacopoeia and the Food Additives Official Standards.

上記第1表より本発明方法によう得られる粉末を用いる
場合、その電解質イオンのばらつきは、実質的に無視で
きるものであり、極めて品質の一定した透析液が供給で
きることが判る。
It can be seen from Table 1 above that when the powder obtained by the method of the present invention is used, the variation in electrolyte ions can be substantially ignored, and a dialysate of extremely constant quality can be supplied.

尚HCO3イオン濃度は、B液として30mEq/lを
用いても、これが酢酸と一部反応してH2CO3となる
ため透析液中では上記27〜28mEq/lとなる。
Note that even if 30 mEq/l is used as the B solution, the HCO3 ion concentration becomes 27 to 28 mEq/l in the dialysate because it partially reacts with acetic acid to form H2CO3.

また上記混合タンク、供給タンク及びコンソール部にお
ける各透析液(A液試料としてロット應1〜5の夫々を
用いたもの)のpH,PO2、ミ1℃02及びHCO3
イオン濃度を調べた結果を下記第2表に示す。
In addition, the pH, PO2, Mi1℃02, and HCO3 of each dialysate (each of lots 1 to 5 were used as liquid A samples) in the mixing tank, supply tank, and console section.
The results of examining the ion concentration are shown in Table 2 below.

尚各測定はガス分析装置(1,L。メーター マイクロ
13.1.L社製)により夫夫行なった。
Each measurement was carried out using a gas analyzer (1.L. Meter Micro 13.1. manufactured by L Co., Ltd.).

上記第2表より、本発明の粉末を用いて調製される重炭
酸透析液は、末端コンソール部において透析膜を通して
患者の血液と接触させるに適したpH7,35以下に保
ち得、そのpHの変動がほとんどなく極めて安定してい
る(中和反応が緩徐に進行する)と共に、HCO3イオ
ン濃度も理論値に近い値で一定しており、更にPCO2
についても透析液として適正な60rn7ILHg前後
の一定値を保持することが判る。
From Table 2 above, it can be seen that the bicarbonate dialysate prepared using the powder of the present invention can be maintained at a pH of 7.35 or less, which is suitable for contacting the patient's blood through the dialysis membrane in the terminal console, and that the pH fluctuation It is extremely stable with almost no PCO2 (the neutralization reaction progresses slowly), and the HCO3 ion concentration remains constant at a value close to the theoretical value.
It can also be seen that a constant value of around 60rn7ILHg, which is appropriate for a dialysate, is maintained.

以上のように本発明によればロット間で実質的にバラツ
キなく常に再現性よ(一定の品質を具備するパイカーボ
ネート透析液が容易に提供できることが明らかである。
As described above, it is clear that according to the present invention, it is possible to easily provide a picarbonate dialysate that has constant quality and is always reproducible without substantial variation between lots.

Claims (1)

【特許請求の範囲】 1 重炭酸透析用人工潅流液を調整するための各電解質
化合物を粉体混合してNaC1,KCl、CaCl2・
2H20,MgCl2・6H20及びCH3COONa
もしくはCH3COONa −3H20からなる電解質
化合物混合粉末を得る方法であって、上記電解質化合物
の主要成分である塩化す) IJウムを予めマイクロナ
イザーで約20〜30μ肌の超微粉とし、次いでこれに
氷酢酸の2〜4重量%を噴霧添加して酢酸酸性とした塩
化ナトリウムの超微粉末を用いることを特徴とする重炭
酸透析用電解質化合物混合粉末の製造方法。 2 電解質化合物混合粉末が酢酸酸性とした塩化ナトリ
ウムを83.263〜88.887重量%、KCI を
0〜4.415重量%、CaCl2・2H20を2.7
20〜3.875重量%、MgCl2・6H20を1.
505〜2.296重量%及びCH3COONaとして
4.048〜8.767重量%含有する特許請求の範囲
第1項に記載の方法。
[Claims] 1. Each electrolyte compound for preparing an artificial perfusion solution for bicarbonate dialysis is mixed in powder form to produce NaCl, KCl, CaCl2,
2H20, MgCl2・6H20 and CH3COONa
Alternatively, there is a method for obtaining an electrolyte compound mixed powder consisting of CH3COONa-3H20, in which IJium (chloride, which is the main component of the electrolyte compound) is made into an ultrafine powder of about 20 to 30 microns using a micronizer, and then glacial acetic acid is added to this. A method for producing an electrolyte compound mixed powder for bicarbonate dialysis, characterized in that ultrafine powder of sodium chloride is made acidic by acetic acid by spraying 2 to 4% by weight of sodium chloride. 2 The electrolyte compound mixed powder contains 83.263 to 88.887% by weight of sodium chloride acidified with acetic acid, 0 to 4.415% by weight of KCI, and 2.7% of CaCl2.2H20.
20-3.875% by weight of MgCl2.6H20 at 1.
505 to 2.296% by weight and 4.048 to 8.767% by weight as CH3COONa.
JP55165121A 1980-11-21 1980-11-21 Method for producing electrolyte compound mixed powder for bicarbonate dialysis Expired JPS5827246B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55165121A JPS5827246B2 (en) 1980-11-21 1980-11-21 Method for producing electrolyte compound mixed powder for bicarbonate dialysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55165121A JPS5827246B2 (en) 1980-11-21 1980-11-21 Method for producing electrolyte compound mixed powder for bicarbonate dialysis

Publications (2)

Publication Number Publication Date
JPS5788116A JPS5788116A (en) 1982-06-01
JPS5827246B2 true JPS5827246B2 (en) 1983-06-08

Family

ID=15806309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55165121A Expired JPS5827246B2 (en) 1980-11-21 1980-11-21 Method for producing electrolyte compound mixed powder for bicarbonate dialysis

Country Status (1)

Country Link
JP (1) JPS5827246B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003435A1 (en) * 1984-02-13 1985-08-15 Tomita Pharmaceutical Corporation Limited Process for producing mixed electrolyte powder for use in bicarbonate dialysis

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4555169A (en) * 1983-09-13 1985-11-26 Canon Kabushiki Kaisha Focus detecting device for a camera
JPS6122865A (en) * 1984-07-11 1986-01-31 扶桑薬品工業株式会社 Replenishing solution for artificial kidney apparatus
FR2614219B1 (en) * 1987-04-23 1993-07-09 Materiels Annexes Dialyse PROCESS FOR THE MANUFACTURE OF GRANULES FOR THE PREPARATION OF DIALYSIS SOLUTIONS AND INSTALLATION FOR ITS IMPLEMENTATION.
JP2749375B2 (en) * 1989-05-26 1998-05-13 テルモ 株式会社 Preparation for hemodialysis and method for producing the same
JP2751933B2 (en) * 1989-05-26 1998-05-18 テルモ 株式会社 Preparation for hemodialysis and method for producing the same
JPH0338527A (en) * 1989-07-06 1991-02-19 Terumo Corp Preparation for blood dialysis and its production
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
JP2739898B2 (en) * 1989-08-07 1998-04-15 日機装株式会社 Dialysate preparation method and dialysate preparation agent
JPH0366622A (en) * 1989-08-07 1991-03-22 Nikkiso Co Ltd Preparation of dialyzing fluid, agent for preparing same fluid and dialyzing fluid preparing device
JPH0984853A (en) * 1995-09-22 1997-03-31 Material Eng Tech Lab Inc Medical container holding organ preservation liquid
TWI516284B (en) 2007-05-31 2016-01-11 味之素股份有限公司 Solid preparation for dialysis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003435A1 (en) * 1984-02-13 1985-08-15 Tomita Pharmaceutical Corporation Limited Process for producing mixed electrolyte powder for use in bicarbonate dialysis
EP0177614B1 (en) * 1984-02-13 1991-09-04 Tomita Pharmaceutical Corporation Limited Process for producing mixed electrolyte powder for use in bicarbonate dialysis

Also Published As

Publication number Publication date
JPS5788116A (en) 1982-06-01

Similar Documents

Publication Publication Date Title
US4655941A (en) Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
JPS5827246B2 (en) Method for producing electrolyte compound mixed powder for bicarbonate dialysis
Schreyer et al. Stability of ferrate (VI) ion in aqueous solution
CA1316034C (en) Powdered packaged developer and a process of preparation
US5071558A (en) Sodium bicarbonate dialysate
AU2018403914B2 (en) Efficient, green and environmental friendly extinguishing agent and preparation method thereof
TWI516284B (en) Solid preparation for dialysis
BRPI0609003B1 (en) thickening composition with improved viscosity-producing properties
CA2020934C (en) Aqueous suspension of hydroxyethylcellulose
JPH02145522A (en) Pasty agent for artificial kidney perfusion and production thereof
US4409353A (en) Easily dispersible composition for water soluble polymer
JPH0892071A (en) Bicarbonate dialyzing agent
US2902446A (en) Methods of preparing alginate suspensions
CA1088040A (en) Alumina
JPH0258210B2 (en)
JP3038414B2 (en) Photographic processing agents
GB748931A (en) Improvements in or relating to the production of foam for fire-fighting purposes
US2406692A (en) Solid complex metal ammine salts and method for the preparation thereof
JP3076051B2 (en) Baking soda dialysis agent
Tsaplev Dimethyl sulfoxide structuring in the presence of aqueous manganese (II) sulfate solution.
WO1993015437A1 (en) Making flowable alkali or ammonium thiosulfate or sulfite and its product-by-process
JPS6353983B2 (en)
AU661895C (en) Method of making flowable alkaline thiosulfate/alkaline sulfite and the product thereof
JPH0591852A (en) Production of thick seasoning liquid
JPH1157059A (en) Manufacture of extinguishing solution